Abstract:Oral biotherapeutics hold significant promise, but their lack of controllability and targeting poses a major challenge, particularly for intestinal bacterial biotherapeutics. In response, we have developed a nanoencapsulation approach that responds to the release of enzyme activity in the organism and activates the enzyme in situ, allowing for controlled colonization of microbes in the gut. The nano-coating comprises a two-layer structure: an inner layer of polydopamine with photothermal and adhesive properties, and an outer layer of gelatin-sodium carboxymethylcellulose, which is hydrolyzed by cellulases in the gut following photothermal interaction with dopamine. We have successfully achieved controlled colonization of a wide range of microorganisms. Furthermore, in a diabetes model, this approach has had a profound impact on regulating glucagon-like peptide-1 (GLP-1) production, β-cell physiology, and promoting insulin secretion. This nanocoating is achieved by in situ activation of cellulase without the need for genetic or targeted molecular modification, representing a new paradigm and alternative strategy for microbial therapy. It not only enables precise and controlled colonization of probiotics but also demonstrates great potential for broader application in the field of oral biotherapy. STATEMENT OF SIGNIFICANCE: We have developed a nano-encapsulation method that triggers enzyme activity in response to enzymatic activity, resulting in the controlled release and adhesion of a wide range of microorganisms in the gut. The nano coating comprises two layers: an inner layer of polydopamine with photothermal and adhesion properties, and an outer layer of a gelatin-sodium carboxymethylcellulose polymer, which can be hydrolyzed by cellulases in the intestine. Additionally, this method allows for the preparation of various microbial coatings. This approach holds significant promise for regulating GLP-1 production, the physiological function of pancreatic β-cells, and promoting insulin secretion in diabetes models.

In Situ Bioorthogonal Conjugation of Delivered Bacteria with Gut Inhabitants for Enhancing Probiotics Colonization

Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.

Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced in Situ Colonization and Immunoregulation of Colitis.

Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease

Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms

Responsively Degradable Nanoarmor-Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation-Targeted Delivery

Probiotics Armed with In Situ Mineralized Nanocatalysts and Targeted Biocoatings for Multipronged Treatment of Inflammatory Bowel Disease

Carboxymethyl Konjac Glucomannan-Chitosan Complex Nanogels Stabilized Emulsions Incorporated into Alginate As Microcapsule Matrix for Intestinal-Targeted Delivery of Probiotics: in Vivo and in Vitro Studies.

Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment

Biofilm-based delivery approaches and specific enrichment strategies of probiotics in the human gut

Metal-Phenolic Network Directed Coating of Single Probiotic Cell Followed by Photoinitiated Thiol-Ene Click Fortification to Enhance Oral Therapy

Microfluidic-based Multifunctional Microspheres for Enhanced Oral Co-Delivery of Probiotics and Postbiotics

A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea

Self-adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery

An oral “Super probiotics” with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment

Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis

Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease

Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered S. boulardii

Multishell Colloidosome Platform with Sequential Gastrointestinal Resistance for On-Demand Probiotic Delivery.

Oral delivery of probiotics using single-cell encapsulation

A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease